This diminution in size has been reported.

There was a lessening in the size of the prostate gland noted in 80% of the patients on finasteride compared with an increased or unchanged size of the prostate in 90% of the patients on alpha-blockers. This supports the previous data of a process in the size of the prostate gland in patients on finasteride. This diminution in size has been reported as durable for 4 to 6 period, which suggests an seizure in the disease physical entity. The measurement of the prostate gland was determined by only a DRE, and this inexact know-how may have a significant lucre of incorrectness compared with a more accurate resolution using sonography. However, Roehborn reports that estimates made by 3 examiners comparing the bulk obtained by DRE with the actual transrectal imaging bulk correlated fairly well with each other.